Your Health, We Care
Release date: 2024-07-10 14:49:13 Recommended: 188
TABRECTA is suitable for treating adult patients with metastatic non-small cell lung cancer (NSCLC), whose tumors have mutations that lead to a jump in exon 14 of mesenchymal epithelial transition (MET) according to FDA approved testing. MET gene mutation is one of the rare mutations in lung cancer, including MET14 jump mutation (3%) and MET amplification (1%).
At a grand pharmaceutical exhibition held recently in Dubai, Lucius Company of L···【more】
Recommended：353Release date: 2024-07-09
On October 18-19, 2023, Dr. Luís Meirinhos Soares, a microbiology expert appoint···【more】
Recommended：362Release date: 2024-07-09
On October 19, 2023, the World Health Organization (WHO) conducted a comprehensi···【more】
Recommended：422Release date: 2024-07-09
At present, the competition in all walks of life is very fierce, especially in t···【more】
Recommended：283Release date: 2024-07-09
Here are some key points about Lucius Pharmaceutical:Lucius Pharmaceuticals has ···【more】
Recommended：476Release date: 2024-07-09
From the Black Sea, the most terrifying ocean on earth, to the Mediterranean Sea···【more】
Recommended：294Release date: 2024-07-09
Dr. Louis, a microbiologist at the World Health Organization (WHO), recently mad···【more】
Recommended：461Release date: 2024-07-09
Lung cancer is the most rapidly increasing malignant tumor with the fastest incr···【more】
Recommended：365Release date: 2024-07-09
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the r···【more】
Recommended：67Release date: 2025-12-17
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved nirap···【more】
Recommended：60Release date: 2025-12-15
The U.S. Food and Drug Administration (FDA) announced today that it has approved···【more】
Recommended：79Release date: 2025-12-10
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisoca···【more】
Recommended：74Release date: 2025-12-08
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full ap···【more】
Recommended：94Release date: 2025-12-04
Primary analysis data from the randomized, double-blind, placebo-controlled phas···【more】
Recommended：89Release date: 2025-12-01
